Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission critical automation solutions to facilitate the manufacturing and release of healthcare products, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company's flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control, testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.
BörsenkürzelRPID
Name des UnternehmensRapid Micro Biosystems Inc
IPO-datumJul 15, 2021
CEOMr. Robert (Rob) Spignesi
Anzahl der mitarbeiter163
WertpapierartOrdinary Share
GeschäftsjahresendeJul 15
Addresse25 Hartwell Avenue
StadtLEXINGTON
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl02421
Telefon19783493200
Websitehttps://www.rapidmicrobio.com/
BörsenkürzelRPID
IPO-datumJul 15, 2021
CEOMr. Robert (Rob) Spignesi
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten